CORMEDIX INC. Warrant To Purchase Common StockCorMedix Inc. • March 4th, 2015 • Pharmaceutical preparations • New York
This Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”) of CorMedix Inc. (the “Company”) is issued this 3rd day of March, 2015 (the “Issuance Date”) to Manchester Securities Corp. (the “Holder”) pursuant to that certain Backstop Agreement, dated the Issuance Date (the “Backstop Agreement”). The Company hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Holder or its permitted assigns is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant, at any time or times on or after March 3, 2015 (the “Initial Exercisability Date”), but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), 200,000 (subject to adjustment as provided herein) fully paid and nonassessable shares of Common Stock
CORMEDIX INC. Amended and Restated Warrant To Purchase Common StockCorMedix Inc. • March 4th, 2015 • Pharmaceutical preparations • New York
This Amended and Restated Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”) of CorMedix Inc. (the “Company”) is issued this 3rd day of March 2015, and amends and restates the Warrant to Purchase Common Stock issued by the Company on May 30, 2013 (the “Issuance Date”) to Manchester Securities Corp. (the “Holder”), pursuant to that certain Securities Purchase Agreement dated May 23, 2013 (the “Securities Purchase Agreement”), which Warrant to Purchase Common Stock was subsequently amended and restated on September 15, 2014. The Company hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Holder or its permitted assigns is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant, at any time or times on or after M
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 4th, 2015 • CorMedix Inc. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of March 3, 2015, by and among (i) CorMedix Inc., a Delaware corporation (the “Company”), and (ii) Manchester Securities Corp. (“Buyer”).
BACKSTOP AGREEMENTBackstop Agreement • March 4th, 2015 • CorMedix Inc. • Pharmaceutical preparations • New York
This BACKSTOP AGREEMENT (this “Agreement”), dated as of March 3, 2015, is entered into by and between CorMedix Inc., a Delaware corporation with offices located at 1430 U.S. Highway 202, Suite 200, Bedminster, NJ 07921 (the “Company”), and Manchester Securities Corp. (the “Buyer”).
